Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Nanning, Guangxi, China.
Sleep Breath. 2024 Oct;28(5):2237-2246. doi: 10.1007/s11325-024-03122-0. Epub 2024 Aug 1.
Asthma is a heterogeneous disorder. This study aimed to identify changes in gene expression and molecular mechanisms associated with moderate to severe asthma.
Differentially expressed genes (DEGs) were analyzed in GSE69683 dataset among moderate asthma and its controls as well as between severe asthma and moderate asthma. Key module genes were identified via co-expression analysis, and the molecular mechanism of the module genes was explored through enrichment analysis and gene set enrichment analysis (GSEA). GSE89809 was used to verify the characteristic genes related to moderate and severe asthma.
Accordingly, 2540 DEGs were present between moderate asthma and the control group, while 6781 DEGs existed between severe asthma and moderate asthma. These genes were identified into 14 co-expression modules. Module 7 had the highest positive correlation with severe asthma and was recognized to be a key module by STEM. Enrichment analysis demonstrated that the module genes were mainly involved in oxidative stress-related signaling pathways. The expression of HSPA1A, PIK3CG and PIK3R6 was associated with moderate asthma, while MAPK13 and MMP9 were associated with severe asthma. The AUC values were verified by GSE89809. Additionally, 322 drugs were predicted to target five genes.
These results identified characteristic genes related to moderate and severe asthma and their corresponding molecular mechanisms, providing a basis for future research.
哮喘是一种异质性疾病。本研究旨在鉴定与中度至重度哮喘相关的基因表达变化和分子机制。
在 GSE69683 数据集分析中度哮喘及其对照以及重度哮喘与中度哮喘之间的差异表达基因(DEGs)。通过共表达分析鉴定关键模块基因,并通过富集分析和基因集富集分析(GSEA)探索模块基因的分子机制。使用 GSE89809 验证与中度和重度哮喘相关的特征基因。
中度哮喘与对照组之间存在 2540 个 DEGs,而重度哮喘与中度哮喘之间存在 6781 个 DEGs。这些基因被分为 14 个共表达模块。模块 7 与重度哮喘的相关性最高,被 STEM 认定为关键模块。富集分析表明,模块基因主要参与氧化应激相关信号通路。HSPA1A、PIK3CG 和 PIK3R6 的表达与中度哮喘相关,而 MAPK13 和 MMP9 与重度哮喘相关。GSE89809 验证了 AUC 值。此外,预测 322 种药物可针对 5 个基因。
这些结果鉴定了与中度和重度哮喘相关的特征基因及其相应的分子机制,为未来的研究提供了基础。